尊龙凯时人生就是搏·(中国区)官方网站
About Us
About Sino Biopharm
Board of Directors
Senior Management
R&D
R&D Team
Products
Product List
Sustainability
ESG Governance
ESG Management Practices
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
News
Press Releases
Contact
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
Information Disclosure
PROFIT WARNING
2022.08.11
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022
2022.08.01
NOTIFICATION OF BOARD MEETING
2022.08.01
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022.07.28
RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER AND APPOINTMENT OF CHIEF EXECUTIVE OFFICER
2022.07.27
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
2022.07.15
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2022
2022.06.30
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING OF CATEGORY 1 INNOVATIVE DRUG “TQ-B3101 CAPSULE”
2022.06.27
首页
上一页
31
32
33
34
35
36
...
53
尾页
下一页